Issue link: https://beckershealthcare.uberflip.com/i/548475
The future of DVT prevention is here 1.Sobieraj-Teague M, Hirsh J, Yip G, et al. Randomized controlled trial of a new portable calf compression device (Venowave) for prevention of venous thrombosis in high-risk neurosurgical patients. Journal of Thrombosis and Haemostasis. 10 (2) (pp 229-235), 2012. 2. O'Donnell, M., Ginsberg, J., Saringer, J., Kearon, C., Magier, D., Kolich, M., Julian, J., Hirsh, J. (2002). Effects of a Novel Venous-Return Assist Device ("Venowave") on Lower Limb Venous Flow in Patients with Post-Thrombotic Syndrome. Journal of the American Society of Hematology, 11(100), Abstract 3950. 3. National Medical Policy from HealthNet: Pneumatic Compression Device (PCD) Post Surgery. September 2013. 4. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis policy review from the BlueCross BlueShield Association, April 2014. 5. Colwell CW Jr, Froimson MI, Mont MA, et al. A Mobile Compression Device for Thrombosis Prevention in Hip and Knee Arthroplasty. J Bone Joint Surg Am. 2014;96:177-83. Introducing the Venowave- a lightweight Mobile Compression Device designed for inpatient and outpatient use, allowing you to provide seamless DVT prevention throughout the entire risk period. The Venowave demonstrated a 79% reduction in VTE occurrence in high risk patients 1 and has been proven to increase blood flow by 88% above baseline after fifty minutes of use. 2 Major insurers have also included the Venowave in recent national medical policies. 3,4 In recent studies, Mobile Compression Devices have been shown to be as effective as LMWH in VTE prevention, with significant reduction in bleeding. 5 To learn more about how the Venowave could benefit your patients, visit www.dvtlite.com or call (877) 593-3546. Venowave Mobile Compression | New Technology